Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage

Anticancer Research

Volumn 25, Issue 3 C, 2005, Pages 2551-2554

  Hwang, Jen I ^a   Chow, Wai Keung ^a   Hung, Siu Wan ^a,b   Li, Tsai Chung ^b   Cheng, Yu Ping ^a   Ho, Yung Jen ^c   Lin, Cheng Chieh ^b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute liver damage; Hepatocellular carcinoma; ICG R15; Lipiodol; Transarterial chemoembolization

Indexed keywords

INDOCYANINE GREEN; IODINATED POPPYSEED OIL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PALLIATIVE THERAPY; CHEMOEMBOLIZATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DOSE RESPONSE; FEMALE; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER INJURY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; SAFETY; TREATMENT OUTCOME; TUMOR VOLUME;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EPIRUBICIN; HUMANS; IODIZED OIL; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; LOGISTIC MODELS; PROSPECTIVE STUDIES;

EID: 22944456854     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kew MC: Epidemiology of hepatocellular carcinoma. Toxicology 181-182: 35-38, 2002.
2. Yeh CN, Lee WC and Chen M-F: Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 10: 1070-1076, 2003.
3. Wudel LJ Jr and Chapman WC: Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am 12: 77-90, 2003.
4. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S and Ueno H: Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. Am J Roentgenol 176: 681-688, 2001.
5. Llovet J M, Real M I, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J and Bruix J: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739, 2002.
6. Saccheri SM, Lovaria AM, Sangiovanni AM, Nicolini AM, De Fazio CM, Ronchi GM, Fasani PM, Del Ninno EM and Colombo MM: Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Intervent Radiol 13: 995-999, 2002.
7. Mickey RM and Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129: 125-137, 1989.
8. Bendel RB: Comparison of stopping rules in forward regression. J Am Stat Assoc 72: 46-53, 1977.
9. Ott P, Keiding S and Bass L: Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration. Eur J Clin Invest 22: 347-357, 1992.
10. Keiding S and Skak C: Methodological limitations of the use of intrinsic hepatic clearance of ICG as a measure of liver cell function. Eur J Clin Invest 18: 507-511, 1988.